DE69418218D1 - Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel - Google Patents

Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel

Info

Publication number
DE69418218D1
DE69418218D1 DE69418218T DE69418218T DE69418218D1 DE 69418218 D1 DE69418218 D1 DE 69418218D1 DE 69418218 T DE69418218 T DE 69418218T DE 69418218 T DE69418218 T DE 69418218T DE 69418218 D1 DE69418218 D1 DE 69418218D1
Authority
DE
Germany
Prior art keywords
pct
derivatives
chinolonylcarboxamidocephalosporine
products containing
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69418218T
Other languages
English (en)
Other versions
DE69418218T2 (de
Inventor
Constantino Miguel Corpi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aranda Lab SA De Cv
Original Assignee
Aranda Lab SA De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aranda Lab SA De Cv filed Critical Aranda Lab SA De Cv
Application granted granted Critical
Publication of DE69418218D1 publication Critical patent/DE69418218D1/de
Publication of DE69418218T2 publication Critical patent/DE69418218T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69418218T 1994-02-25 1994-10-07 Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel Expired - Fee Related DE69418218T2 (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
MX9401427 1994-02-25
MX9403331 1994-05-06
MX9403394 1994-05-09
MX9406682 1994-09-01
MX9406681 1994-09-01
MX9406680 1994-09-01
MX9407838 1994-09-05
PCT/IB1994/000304 WO1995023153A1 (en) 1994-02-25 1994-10-07 Quinolonylcarboxamidocephalosporin derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DE69418218D1 true DE69418218D1 (de) 1999-06-02
DE69418218T2 DE69418218T2 (de) 1999-11-04

Family

ID=27567169

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418218T Expired - Fee Related DE69418218T2 (de) 1994-02-25 1994-10-07 Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel

Country Status (8)

Country Link
US (1) US5728691A (de)
EP (1) EP0746561B1 (de)
AT (1) ATE179422T1 (de)
AU (1) AU7706394A (de)
CO (1) CO4340690A1 (de)
DE (1) DE69418218T2 (de)
ES (1) ES2132430T3 (de)
WO (1) WO1995023153A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3710695A (en) * 1995-04-27 1996-11-18 Laboratorios Aranda, S.A. De C.V. Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
MX365890B (es) * 2004-06-24 2019-06-19 Vertex Pharma Moduladores de transportadores con casete de unión con atp.
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US7573973B2 (en) * 2005-05-17 2009-08-11 General Electric Company Methods and systems to facilitate reducing cone beam artifacts in images
AU2006331614A1 (en) * 2005-12-24 2007-07-05 Vertex Pharmaceuticals Incorporated Quinolin- 4 - one derivatives as modulators of ABC transporters
RS55940B1 (sr) 2005-12-28 2017-09-29 Vertex Pharma Čvrsti oblici n-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksohinolin-3-karboksamida
SG174410A1 (en) 2009-03-20 2011-11-28 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
RU2692779C2 (ru) 2012-02-27 2019-06-27 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтическая композиция и ее введения
EP3204358B1 (de) 2014-10-07 2018-09-19 Vertex Pharmaceuticals Incorporated Cokristalle von modulatoren des transmembrankonduktanzregulators bei zystischer fibrose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468394A (en) * 1981-04-02 1984-08-28 Eisai Co., Ltd. Cephalosporin compounds
US4404201A (en) * 1981-11-13 1983-09-13 Warner-Lambert Company Cephalosporins
ZA874696B (en) * 1986-07-03 1988-01-04 F. Hoffmann-La Roche & Co. Aktiengesellschaft Acyl derivatives
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
EP0366193A3 (de) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Antimikrobielle Quinolonyllactame
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren

Also Published As

Publication number Publication date
US5728691A (en) 1998-03-17
EP0746561A1 (de) 1996-12-11
WO1995023153A1 (en) 1995-08-31
AU7706394A (en) 1995-09-11
EP0746561B1 (de) 1999-04-28
DE69418218T2 (de) 1999-11-04
ES2132430T3 (es) 1999-08-16
CO4340690A1 (es) 1996-07-30
ATE179422T1 (de) 1999-05-15

Similar Documents

Publication Publication Date Title
IL112111A0 (en) Peptide derivatives and pharmaceutical compositions containing them
BG101118A (en) Therapeutical compounds
NZ284846A (en) 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
BG101209A (en) Hypolipidemic compounds
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
BG102857A (en) Antimycotic substance-containing and acetate buffer-containing compositions
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
DE69418218D1 (de) Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
HUP0004282A2 (hu) 2-Halogén-6-0-szubsztituált ketolidszármazékok
PL329027A1 (en) Derivatives of benzopyrane exhibiting antagonistic activity in respect to leucotriene
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
WO1996022305A3 (en) Modified peptides
ATE293895T1 (de) Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen
BG105275A (en) Tan-1057 derivatives
AU6122994A (en) Hiv protease inhibitors and their preparation
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
GR1002576B (el) Φαρμακευτικες συνθεσεις και μια μεθοδος παρασκευης τους.
IL105454A0 (en) Water-soluble retinoids,their preparation and pharmaceutical and cosmetic compositions containing them

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee